Introduction Rybelsus is the brand name of oral semaglutide, a glucagon-like peptide-1 receptor agonist used in the management of type 2 diabetes mellitus. It is pharmacologically important because it is an orally administered GLP-1 receptor agonist, unlike many other GLP-1 receptor agonists that are given by subcutaneous injection. Rybelsus is used along with diet and … Read more
Introduction GLP-1 receptor agonists are a class of antidiabetic drugs that mimic the action of glucagon-like peptide-1 (GLP-1), an incretin hormone that enhances insulin secretion in response to meals. These agents are used primarily in the treatment of type 2 diabetes mellitus and obesity. Their unique ability to improve glycemic control without causing significant hypoglycemia, … Read more
Introduction Semaglutide (Ozempic for diabetes; Wegovy for obesity) is a GLP‑1 receptor agonist used for type 2 diabetes mellitus management and chronic weight loss. It mimics the incretin hormone glucagon‑like peptide‑1 (GLP‑1), leading to improved glycemic control, reduced appetite, delayed gastric emptying, and favorable effects on cardiovascular risk. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value … Read more
